Press release
EuroNoxx Medical Group Ltd and Allengers Announce Exclusive UK Distribution Agreement for Cutting-Edge Medical Devices
London, 1st August 2024 - EuroNoxx Medical Group Ltd and Allengers are excited to unveil a new strategic partnership that will see EuroNoxx become the exclusive distributor of Allengers' advanced medical devices across the United Kingdom. This collaboration represents a significant step forward in advancing healthcare through the introduction of groundbreaking technology to the UK market.As part of this exclusive agreement, EuroNoxx Medical Group Ltd will bring Allengers' renowned imaging systems and diagnostic tools to hospitals and clinics throughout the UK. This partnership aims to provide healthcare professionals with state-of-the-art equipment to enhance patient care and improve clinical outcomes.
Announcing the Breast Cancer 2024 Symposium
In celebration of this landmark partnership, EuroNoxx Medical Group Ltd is thrilled to be a key sponsor and organiser of the upcoming Breast Cancer 2024 Symposium. This prestigious event, organised in conjunction with Koning Corporation, the London International Medical School, and
Allengers, will be a cornerstone event in the breast cancer care calendar.
The symposium will feature cutting-edge presentations on the latest advancements in breast cancer diagnostics, including insights into innovative technologies from Allengers and Koning Corporation. Participants will have the chance to engage with leading experts, take part in dynamic panel discussions, and explore future trends in breast cancer detection and treatment.
Dr Mandeep Goma, Managing Director of EuroNoxx Medical Group Ltd, expressed enthusiasm about the partnership, stating, "We are delighted to partner with Allengers to bring their exceptional technology to the UK. This agreement underscores our commitment to improving healthcare standards. The Breast Cancer 2024 Symposium is the perfect platform to showcase these advancements and drive meaningful conversations about the future of breast cancer care."
Dr Rajiv Malhotra, CEO of Allengers, added, "Our collaboration with EuroNoxx Medical Group Ltd is an exciting development for us. We are eager to introduce our advanced technology to the UK market and contribute to the ongoing battle against breast cancer. We look forward to engaging with the healthcare community at the Breast Cancer 2024 Symposium and demonstrating how our innovations can make a difference."
Event Details:
- Date: Saturday, 7 September 2024
- Time: 9:00 am - 5:00 pm
- Venue: Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE
- Contact: +44 20 3642 1175 | symposium24@euronoxxmedical.com
This symposium promises to be a pivotal event for professionals and stakeholders in breast cancer care, offering a unique opportunity to engage with the latest innovations and foster collaborative progress.
For further details on the exclusive agreement with Allengers and the Breast Cancer 2024 Symposium, please reach out to EuroNoxx Medical Group Ltd at symposium24@euronoxxmedical.com.
About Allengers:
Allengers is a global leader in the design and manufacture of medical imaging and diagnostic equipment. Renowned for its commitment to innovation and quality, Allengers provides healthcare professionals with the tools necessary for exceptional patient care.
Media Contact:
Ed Beasley
Digital Marketing Manager
EuroNoxx Medical Group Ltd
Contact: +44 20 3642 1175 | info@euronoxxmedical.com
www.euronoxxmedical.com
35 Berkeley Square, Mayfair, London, UK, W1J 5BF
About EuroNoxx Medical Group Ltd:
EuroNoxx Medical Group Ltd is at the forefront of advancing healthcare in the UK by providing innovative medical solutions. Specialising in the distribution of medical equipment and surgical devices, EuroNoxx is committed to supporting the NHS and private hospitals with cutting-edge technology and expert support.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EuroNoxx Medical Group Ltd and Allengers Announce Exclusive UK Distribution Agreement for Cutting-Edge Medical Devices here
News-ID: 3628329 • Views: …
More Releases for Allengers
Electroencephalography Devices Market to Witness USD 2.6 billion by 2031- Medtro …
The Electroencephalography (EEG) Devices Market reached USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2031, growing at a CAGR of 9.4% during the forecast period from 2024 to 2031.
An electroencephalogram (EEG) is a diagnostic test that measures electrical activity in the brain using small metal discs (electrodes) attached to the scalp. Brain cells communicate via electrical impulses and are active continuously, even during sleep.…
Portable EEG Machine Market Business Standards - Allengers Medical Systems, Brai …
A recent market research report entitled Portable EEG Machine Market 2023 done by MarketsandResearch.biz obtains factual data, deliberately significant contender data, and insights of knowledge related to the market. The report draws attention towards a range of factors such as current and historical circumstances as well as developments, noteworthy business techniques. The report determines historic growth analysis and current scenario of global Portable EEG Machine industry marketplace and intends…
Smart Hospital Market to Witness Massive Growth | Microsoft, GlucoVista, Allenge …
Advance Market Analytics published a new research publication on "Smart Hospital Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Smart Hospital market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Kidney Stone Management Market Size, Company Profiles And Key Figures Reviewed I …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Kidney Stone Management, which includes a detailed analysis based on competitors and important market segments (2022-2030). The Global Kidney Stone Management provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both…
Kidney Stone Management Market 2030 by Keyplayers and Vendors: Allengers Medical …
Newark, New Castle, USA: Growth Plus Reports recently introduced a new title on Kidney Stone Management Market 2022 and forecast 2030 from its database. The Kidney Stone Management report provides a study with an in-depth overview, describing the product/industry scope and elaborates market outlook and status (2022-2030). The Kidney Stone Management report is curated after in-depth research and analysis by experts. The Kidney Stone Management report provides comprehensive valuable insights…
Smart Hospital Market to See Major Growth by 2027 | Philips, Medtronic, Allenger …
The latest study released on the Global Smart Hospital Market by AMA Research evaluates market size, trend, and forecast to 2027. The Smart Hospital market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in…
